Seeking Alpha

Shares of Protalix (PLX) +4.4% premarket after a report says the firm will file a request with...

Shares of Protalix (PLX) +4.4% premarket after a report says the firm will file a request with the FDA within days for approval of the firm's Gaucher's disease treatment Uplyso.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)